JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne

Published online June 1, 2026

Acne vulgaris is one of the most prevalent and deleterious skin disease conditions patients can experience in their lifetime, with bot...

read more
A Randomized Controlled Trial Analyzing the Likeability, Usability, and In-Use Efficacy of Mineral Sunscreens Across Diverse Skin Tones

Published online May 31, 2026

Consistent sunscreen use can reduce risk for non-melanoma and melanoma skin cancers and is thus recommended by government agencies and ...

read more
Safety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles

Published online May 30, 2026

Sculptra ® poly-L-lactic acid (PLLA-SCA, Galderma) is a regenerative biostimulator containing microparticles of PLLA, a biocompati...

read more
Randomized Controlled Study of Bacteriophages in Acne Reveals Efficacy and Novel Mechanism for Promoting Long-Term Skin Health

Published online May 30, 2026

Acne is a chronic inflammatory disease of the pilosebaceous unit with multifactorial etiology and a significant mental health compone...

read more
Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne

Published online May 29, 2026

Acne vulgaris is among the most common dermatologic conditions worldwide. 1,2 Acne typically begins during adolescence and may persist...

read more
Understanding Patient Perspectives on Rosacea: A Cross-Sectional Analysis of the r/Rosacea Forum on Reddit

Published online May 29, 2026

Rosacea is a chronic inflammatory disease characterized by recurrent facial flushing, erythema, papules, and pustules. While its precis...

read more
Efficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne

Published online May 29, 2026

Acne vulgaris is an inflammatory skin disorder with a global prevalence of 9.4% and 231.2 million cases reported worldwide in 2019. 1 ...

read more
Generalized Bullous Fixed-Drug Eruption in a 15-Year-Old Child With Becker Muscular Dystrophy and Epilepsy

Published online May 27, 2026

Fixed drug eruption (FDE) is a common type of cutaneous adverse drug reaction that typically presents with the recurrence of single or ...

read more
Update on Granulomatous Dermatoses: Clinical Features and Therapeutic Advances

Published online May 27, 2026

Granulomatous dermatoses (GDs) are a group of diseases defined by organized granuloma formation within the dermis or hypodermis, ofte...

read more
Increased Postoperative Risks After Mohs Surgery in Patients With Hypothyroidism: A Cohort Study

Published online May 27, 2026

To the Editor, A direct relationship between hypothyroidism and delayed wound healing has been demonstrated in both in vivo murine and ex vivo hum...

read more
Trends in Fluorouracil and Calcipotriene Utilization for Actinic Keratosis

Published online May 27, 2026

To the Editor, Actinic keratoses (AKs) are skin lesions that can progress to squamous cell carcinomas. When multiple AKs occur in one area, field ...

read more
Perioperative Use of Angiotensin Inhibitors and Their Complications in Mohs Surgery: A Retrospective Cohort Study

Published online May 26, 2026

Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) are among the most commonly prescribed antihy...

read more
Psychotherapeutic Interventions in Acne Vulgaris: A Call for Future Research

Published online May 27, 2026

Acne vulgaris is a chronic inflammatory skin condition that makes up a significant proportion of dermatology consultations. 1 The glob...

read more
A Review of the Relationship Between Cutibacterium acnes, Biofilms, and Keratosis Pilaris

Published online May 26, 2026

Keratosis pilaris (KP) is a very common, benign dermatological disorder with characteristic small keratotic papules in a folliculocentr...

read more
Predicting Benefit of Adjuvant Radiation Therapy for Cutaneous Squamous Cell Carcinoma: A Systematic Review

Published online May 26, 2026

Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer, and its incidence is rising. 1,2 The majority of cS...

read more
Treating Acne Vulgaris and Scarring With Botulinum Toxin: A Systematic Review

Published online May 19, 2026

Acne vulgaris is a debilitating disease involving the sebaceous glands and the proliferation of Propionibacterium acnes (P. acnes). Thi...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

New Innovations with SkinCeuticals: Future Mineral UV Defense and P-TIOX Cream

| JDD Highlights, JDD Webinars, The Latest | No Comments
Join Dr. Luis Macias, a double board-certified plastic surgeon, to learn more about new innovations of SkinCeuticals.  Dr. Macias will present the latest science from SkinCeuticals.   Faculty Luis Macias,…
Journal of Drugs in Dermatology JDD featuring Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel

Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel

| Featured Articles, Latest News, Oncodermatology, Skin Cancer | No Comments
New JDD Consensus Offers Practical Guidance on Cosibelimab for Advanced cSCC Have you read this article from the JDD  A recent expert consensus addresses cosibelimab, a newly FDA approved PD-L1…
DermEdge Free CME Platform

Forefront Dermatology partners with MedscapeLive! to present a new CME Webinar Series, DermEdge

| Derm Community, Education, Latest News, NP/PA Education | No Comments
Discover a smarter way to meet your continuing medical education requirements DermEdge is a free CME platform from Forefront Dermatology and MedscapeLive! designed for today’s busy dermatology professionals. This on-demand…

JDD in the News: Topical Nonsteroidals for Chronic Hand Eczema

| Featured Articles, JDD in the Media, Latest News | No Comments
Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…

Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study

| Aesthetics, Dyspigmentation, Featured Articles, Latest News | No Comments
Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…

Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study

| Featured Articles, Latest News, Oncodermatology, Skin Cancer | No Comments
Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous adverse events that prevent our patients from having their chemo cake and eating it, too. Never fear as the supportive oncoderms are here….well just two, podcast host Dr. Adam Friedman and guest Dr. Jonathan Leventhal, Associate Professor of Dermatology, the Dermatology Residency Program Director and Director of the Oncodermatology Clinic at the Yale Cancer Center. Curl up with your favorite blanket and learn about the most recent multidisciplinary-guided algorithm for preventing and managing cutaneous targeted therapy related adverse events in cancer patients (as one does). From erosive stomatitis to other dermatologic complications, this podcast is packed with actionable insights to ensure your patients can focus on fighting cancer without unnecessary setbacks. You are going to want to listen up!

Treat to (Stay on) Target(ted Therapies)

| Featured Articles, Featured Podcast, Podcast Highlights, Skin Cancer, The Latest | No Comments
Featured Podcast Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous…
Tune In

Follow Us